The largest database of trusted experimental protocols

Centro xs3 luminometer

Manufactured by Berthold Technologies
Sourced in United States, Germany

The Centro XS3 luminometer is a compact and versatile instrument designed for the detection and quantification of luminescent signals. It utilizes a high-sensitivity photomultiplier tube (PMT) to provide accurate measurements of various luminescent assays, including those involving luciferase, aequorin, and other bioluminescent reporters.

Automatically generated - may contain errors

5 protocols using centro xs3 luminometer

1

NADP+/NADPH Quantification in LN-308 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
LN-308 cells were treated for 24 h with 2.5 nM Tunicamycin (or DMSO as a control) and subsequently washed with PBS prior to harvesting. For each assay, 4 × 104 cells were resuspended in 50 µl of PBS and lysed with an equal volume of a solution containing 1% DTAB in 0.2 N NaOH. NADPH and NADP+ concentrations were determined with the NADP/NADPH-GloTM assay (Promega) according to the manufacturer’s instructions. In brief, samples were split into aliquots of 50 µl each and subjected to treated either with acid (25 μl of 0.4 N HCl to determine NADP+ levels) or base (to determine NADPH levels). Samples were incubated for 15 min at 60 °C, cooled to room temperature and neutralized with Tris. 50 µl of each sample were then mixed with an equal volume of NADP/NADPH-GloTM detection reagent and after incubation for 45 min subjected to luminescence measurement using a Centro XS3 luminometer (Berthold).
+ Open protocol
+ Expand
2

Single-round HIV-1 Env-mediated Infection Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A single-round infection assay was performed as previously described.8 ,29 (link) Briefly, HIV-1 Env ligands (antibodies and sCD4) were diluted in DMEM, and 30 μL of each tested concentration were manually dispensed in a 96-well microplates (Greiner bio-one; catalogue no. 655083). Then 30 μL containing 2 ng of p24 of viruses pseudotyped with specific Envs were then added, and after a brief incubation at room temperature, 30 μL of 1.7 × 105 Cf2-CD4/CCR5 target cells/mL in DMEM were added. After 48 h incubation, the medium was aspirated and cells were lysed with 30 μL of lysis buffer [(25 mM Tris, 2 mM trans-1,2-diaminocyclohexane-N,N,N′,N′-tetra acetic acid monohydrate, 1% Triton X-100, 10% glycerol, 2 mM dithiothreitol) titered with 15% phosphoric acid (H3PO4) to pH 7.8]. The activity of the firefly luciferase, which was used as a reporter protein in the system, was measured with a Centro XS3 luminometer (Berthold Technologies, TN, USA). The effect of exposure to cold on virus infectivity was measured as previously described in detail.29 (link)
+ Open protocol
+ Expand
3

Transfection and Luciferase Assay for Smo Knockout Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Maintenance and transfection of 4C20 Smo−/− mouse embryonic fibroblasts as well as GLI-luciferase reporter assays were performed as previously described11 (link). In brief, 4C20 Smo−/− cells (authenticated by presence of genomic knockout by PCR and absence of SMO protein by western blot and peri-odically tested for mycoplasma contamination; from the P. A. Beachy laboratory) were seeded into 24-well plates and transfected with various plasmids along with a mixture of 8×GLI-luciferase and SV40-Renilla plasmids using TransIT 2020 transfection reagents (Mirus), following manufacturer’s instructions. For each well, 2.5 ng of Smo cDNA, 125 ng 8×GLI-luciferase plasmid, 5 ng SV40-Renilla plasmid and 120 ng GFP expression plasmid were used for transfection. After the cells grew to confluency, the medium was replaced with DMEM containing 0.5% serum and various drugs or vehicle control. Cholesterol–MβCD inclusion complexes were prepared as previously described53 (link). In brief, a 1:10 molar ratio of cholesterol:MβCD was prepared by adding 9% (w/v) MβCD (Sigma 332615, lot no. STBC2412V, 1.6–2.0 mol CH3 per unit anhydroglucose) to dried cholesterol, heating to 80 °C and sonicating until a clear solution was achieved. Luciferase activity was measured after 48 h of drug treatment using the Dual luciferase assay kit (Promega) on a Berthold Centro XS3 luminometer.
+ Open protocol
+ Expand
4

Luciferase assay for Ptch1-/- MEFs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The luciferase assay was performed in Ptch1−/− MEFs, as previously described(Myers et al., 2017 (link)). Ptch1−/− MEFs were seeded into 24-well plates and then transfected with various plasmids along with a mixture containing 8xGli firefly luciferase and SV40-renilla luciferase plasmids. For each well, 2ng (0.4%) plasmid encoding Ptch1-B variants, or 5ng (1%) plasmid encoding full-length PTCH1 was used. When cells were confluent, they were shifted to DMEM with 0.5% serum containing ShhN-conditioned medium or control medium and incubated for 48 hr. Luciferase activity was then measured using a Berthold Centro XS3 luminometer. The ShhN conditioned medium was prepared from 293 cells transfected with a plasmid expressing the amino signaling domain of Shh. In brief, 293 cells were transfected with the ShhN expression plasmid with lipofectamine 2000. Twelve hours after transfection, culture medium was replaced with 2% FBS low-serum medium. The conditioned medium was then collected 48hours after medium change, and used at 1:10 for the luciferase assays.
+ Open protocol
+ Expand
5

SARS-CoV-2 Spike RBD Antibody Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using luciferase immunoprecipitation system (LIPS) (33 (link)), we measured IgG binding to recombinant nanoluciferase-tagged antigens corresponding to SARS-CoV-2 Wuhan-Hu-1 spike RBD domains, as previously described (34 (link)). Viral sequences used in this study corresponded to the deposited sequence Genebank NC_045512.2 for SARS-CoV-2 Wuhan. Briefly, we cloned recombinant nanoluciferase-tagged antigens and expressed them by transient transfection into Expi293F™ cells (Expi293™ Expression System, ThermoFisher Scientific Life Technologies, Carlsbad, CA, USA). For LIPS, we incubated in liquid phase each antigen with test serum (1 µl) for 2 h and then captured immune complexes with rProtein A-sepharose. After washing (5 times) the sepharose pellets, we quantified bound IgG by measuring the recovered luciferase activity in a Berthold Centro XS3 luminometer (Berthold Technologies GmbH & Co. KG, Bad Wildbad, Germany) using the MikroWin version 5.22 software. We then converted raw data into arbitrary units (AU), using a local positive index serum for SARS-CoV-2-specific antibodies.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!